Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of XALT 20 mg vs Xarelto 20 mg under fed conditions in healthy Thai volunteers
TCTR20210913004Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- Nov 2021
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial (2 arms), sponsored by International Bio Service. Planned start Nov 2021; status: not yet recruiting.
Beyond the preview
Go deeper on TCTR20210913004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210913004.